$HIMS
Hims & Hers Health, Inc.

2019 Q2 Form 10-K Financial Statement

#000119312520088778 Filed on March 27, 2020

View on sec.gov

Income Statement

Concept 2019 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$16.61K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$16.61K
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $500.0K
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $536.3K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.98K
YoY Change
Accrued Expenses $449.1K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $100.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $527.9K
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $527.9K
Total Long-Term Liabilities $0.00
Total Liabilities $500.0K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$16.61K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $0.00
YoY Change
Total Liabilities & Shareholders Equity $536.3K
YoY Change

Cashflow Statement

Concept 2019 Q2
OPERATING ACTIVITIES
Net Income -$16.61K
YoY Change
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $0.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 0.000
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Assets
Assets
204765183
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
478577
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
18475
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
979394
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3852147
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1147262
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5000009
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
204765183
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1510341
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
147500
CY2019Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
203107342
CY2019Q4 oacu Accrued Expensed Related Party Current
AccruedExpensedRelatedPartyCurrent
54839
CY2019Q4 oacu Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7043750
CY2019Q4 oacu Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
150000
CY2019Q4 us-gaap Liabilities
Liabilities
8173144
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
191592030
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1657841
CY2019Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
427503
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
710080
us-gaap Net Income Loss
NetIncomeLoss
1147262
us-gaap Operating Income Loss
OperatingIncomeLoss
-710080
us-gaap Investment Income Interest
InvestmentIncomeInterest
1857342
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
oacu Capital Units Value Of Shares Issued During Period
CapitalUnitsValueOfSharesIssuedDuringPeriod
201250000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
11855223
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6025000
us-gaap Temporary Equity Issue Period Increase Or Decrease
TemporaryEquityIssuePeriodIncreaseOrDecrease
-191592030
us-gaap Investment Income Interest
InvestmentIncomeInterest
1857342
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
147500
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
450081
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
18475
oacu Increase Decrease In Accrued Expensed Related Party
IncreaseDecreaseInAccruedExpensedRelatedParty
-54839
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-241682
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
201250000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-201250000
oacu Proceeds From Issuance Of Capital Units
ProceedsFromIssuanceOfCapitalUnits
201250000
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
6025000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4211257
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
203002023
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1510341
CY2019Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
11900000
CY2019Q3 oacu Investment Securities Maturity Period
InvestmentSecuritiesMaturityPeriod
P185D
CY2019Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.00
CY2019Q4 us-gaap Cash
Cash
1500000
CY2019Q4 oacu Working Capital
WorkingCapital
678000
oacu Proceeds From Issuance Of Founder Shares
ProceedsFromIssuanceOfFounderShares
25000
CY2019Q4 oacu Advances From Related Party
AdvancesFromRelatedParty
62000
CY2019Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2019Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
25000
CY2019Q2 oacu Percentage Of Founder Shares On Outstanding Shares
PercentageOfFounderSharesOnOutstandingShares
0.20
oacu Common Stock Shares Resale Or Transfer Share Price Threshold
CommonStockSharesResaleOrTransferSharePriceThreshold
12.00
oacu Advances From Related Party Agreed Amount
AdvancesFromRelatedPartyAgreedAmount
300000
CY2019Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
10000
dei Document Type
DocumentType
10-K
dei Document Period End Date
DocumentPeriodEndDate
2019-12-31
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
dei Entity Registrant Name
EntityRegistrantName
Oaktree Acquisition Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001773751
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
92503
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
61720
CY2019Q2 oacu Regulatory Withdrawal
RegulatoryWithdrawal
325000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q3 oacu Business Combination Covenants To Proceed With Business Combination
BusinessCombinationCovenantsToProceedWithBusinessCombination
In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination.
CY2019Q3 oacu Description Of Results For Non Compliance With Business Combination
DescriptionOfResultsForNonComplianceWithBusinessCombination
The Company’s Sponsor, officers and directors (the “initial shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, or July 22, 2021
CY2019Q3 oacu Business Combination Requisites To Be Satisfied
BusinessCombinationRequisitesToBeSatisfied
The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on income earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.
CY2019 oacu Annual Threshold Limit Regulatory Withdrawal
AnnualThresholdLimitRegulatoryWithdrawal
325000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div><div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 4%; font-family: &quot;times new roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-align: justify;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment.&#160;It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future conforming events.&#160;Accordingly, the actual results could differ from those estimates. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
oacu Common Stock Conversion Description
CommonStockConversionDescription
20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity- linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor upon conversion of Working Capital Loans.
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2019Q4 oacu Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
-28496
CY2019Q4 oacu Offering Costs Paid By Related Parties
OfferingCostsPaidByRelatedParties
396720
CY2019Q4 oacu Deferred Underwriting Commissions Recognized In Ipo
DeferredUnderwritingCommissionsRecognizedInIpo
7043750
CY2019Q4 oacu Deferred Legal Fees Recognized In Ipo
DeferredLegalFeesRecognizedInIpo
150000
CY2019Q4 oacu Offering Costs Paid By Sponsor In Exchange For Issuance Of Classb Ordinary Shares
OfferingCostsPaidBySponsorInExchangeForIssuanceOfClassbOrdinaryShares
-25000
CY2019Q4 oacu Working Capital Loan
WorkingCapitalLoan
0
oacu Annual Threshold Limit Regulatory Withdrawal
AnnualThresholdLimitRegulatoryWithdrawal
325000
dei Entity Shell Company
EntityShellCompany
true
dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019Q4 dei Entity Public Float
EntityPublicFloat
199237500
oacu Investment Income Interest Net Of Regulatory Withdrawal
InvestmentIncomeInterestNetOfRegulatoryWithdrawal
1500000

Files In Submission

Name View Source Status
0001193125-20-088778-index-headers.html Edgar Link pending
0001193125-20-088778-index.html Edgar Link pending
0001193125-20-088778.txt Edgar Link pending
0001193125-20-088778-xbrl.zip Edgar Link pending
d867475d10k.htm Edgar Link pending
d867475dex141.htm Edgar Link pending
d867475dex311.htm Edgar Link pending
d867475dex312.htm Edgar Link pending
d867475dex321.htm Edgar Link pending
d867475dex322.htm Edgar Link pending
d867475dex42.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
oacu-20191231.xml Edgar Link completed
oacu-20191231.xsd Edgar Link pending
oacu-20191231_cal.xml Edgar Link unprocessable
oacu-20191231_def.xml Edgar Link unprocessable
oacu-20191231_lab.xml Edgar Link unprocessable
oacu-20191231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending